McKesson Co. (NYSE:MCK) Shares Bought by WD Rutherford LLC

WD Rutherford LLC lifted its position in shares of McKesson Co. (NYSE:MCK) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,713 shares of the company’s stock after purchasing an additional 329 shares during the quarter. WD Rutherford LLC’s holdings in McKesson were worth $3,256,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in MCK. Creative Planning raised its position in shares of McKesson by 2.1% in the third quarter. Creative Planning now owns 63,328 shares of the company’s stock worth $31,064,000 after acquiring an additional 1,316 shares during the period. Good Life Advisors LLC raised its holdings in McKesson by 36.9% in the 3rd quarter. Good Life Advisors LLC now owns 1,064 shares of the company’s stock worth $526,000 after purchasing an additional 287 shares during the period. Trust Co. of Vermont boosted its position in McKesson by 7.8% during the third quarter. Trust Co. of Vermont now owns 375 shares of the company’s stock worth $185,000 after purchasing an additional 27 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in McKesson by 0.3% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 15,483 shares of the company’s stock valued at $7,655,000 after purchasing an additional 50 shares during the period. Finally, V Square Quantitative Management LLC increased its position in shares of McKesson by 27.0% in the third quarter. V Square Quantitative Management LLC now owns 1,129 shares of the company’s stock valued at $558,000 after buying an additional 240 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 579 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the transaction, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders sold 1,346 shares of company stock valued at $795,275. Company insiders own 0.11% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Evercore ISI lifted their price target on shares of McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday, February 6th. StockNews.com downgraded shares of McKesson from a “strong-buy” rating to a “buy” rating in a research report on Friday. Wells Fargo & Company lifted their price objective on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a report on Friday, December 13th. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Finally, Morgan Stanley lifted their price target on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and a consensus target price of $645.79.

McKesson Stock Performance

MCK opened at $593.82 on Friday. The stock has a market capitalization of $74.42 billion, a PE ratio of 27.19, a P/E/G ratio of 1.30 and a beta of 0.52. McKesson Co. has a one year low of $464.42 and a one year high of $637.51. The business’s 50 day moving average price is $587.26 and its 200 day moving average price is $563.09.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. As a group, equities research analysts forecast that McKesson Co. will post 32.69 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be issued a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. McKesson’s dividend payout ratio is currently 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.